GM-XANTHO not checked

Xantho Biotechnology Co., LTD

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
6 active
8 in total · 6 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Psoriasis, Pressure Ulcer, Diabetes Mellitus
Main trialPhase 2
“This trial is a Phase IIa clinical trial. Around 65 subjects will be enrolled into this study to primarily assess the treatment efficacy of 5% GM-XANTHO in patients with psoriasis, as well as the safety and tolerability of 5% GM-XANTHO. Two third of the total subjects will be given the investigational product, 5% GM-XANTHO, and the other third will take placebo. The treatment period will last for 28 consecutive days, followed by a safety follow-up for 2 weeks. During the study, there will be 8 scheduled visits to the clinical center.”In the company’s words, NCT06620692 on ClinicalTrials.gov

Other drugs for Psoriasis

All 41 drugs for Psoriasis

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 2Not yet recruiting 31 Dec 2027 A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients With Psoriasis
Phase 2Not yet recruiting 31 Dec 2028 A Study of GM-XANTHO in Pressure Ulcer Patients
Phase 3Authorised not given A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Phase 3Authorised not given A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by birch pollen exposure
Phase 3/4Ended not given The effects of the manipulation of 5-HT, DA and NA on exercise-induced fatigue and brain activation
Phase 2Not authorised not given A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE
Phase 2Authorised not given Tocotrienol and bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial
Phase 3Authorised not given Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter randomized controlled non-inferiority study (RIFREE)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow GM-XANTHO

Following is part of Solo: you see every change to GM-XANTHO the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in